80% of women with polycystic ovary syndrome (PCOS) have irregular or absent periods.
Only about 20% of women with PCOS ovulate.
PCOS impacts egg quality in fertility treatments like IVF. Addressing hormonal imbalances can enhance egg quality in PCOS women.
Myo-inositol improves egg quality by helping regulate hormone levels and by inducing the synthesis of melatonin – increasing the chances of successful conception when trying to conceive naturally or undergoing Assisted Reproductive Technologies, such as IVF and ICSI.
If you are trying to get pregnant, this is great news as the production of a healthy egg is needed if you are to have a baby.
There are some changes you can make to your lifestyle.
There are a number of PCOS-related factors which are likely to cause poor-quality eggs. These include: hyperandrogenemia, hypersecretion of LH, FSH deficiency and hyperinsulinemia with insulin resistance. They all increase the risks of poor egg quality, which can lead to implantation failure and miscarriage.
Those with PCOS experience changes in hormone levels that make it difficult for the ovaries to release fully-grown (mature) eggs. Many of those with PCOS actually don’t release mature eggs, but the eggs stay in the ovaries within a cyst (a small amount of fluid) and the ovary can be enlarged. There can be multiple cysts, but it is important to note that not all women with PCOS have cysts.
